Not Yet RecruitingPhase 4

Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia

United States2,096 participantsStarted 2026-02-01

Plain-language summary

The purpose of this study is to see if, in selected patients with a serious bacterial infection of the bloodstream, treating the bacterial infection with a combination of antibiotics is more effective than treating the infection with a single antibiotic. Participants must have blood cultures which are positive for a certain type of bacteria.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. on or during the index admission to an IH hospital, or
✓. in an ambulatory setting (laboratory, clinic or emergency department) within 48 hours of the index admission, or
✓. at a non-IH network hospital within 24 hours of subsequent transfer to an IH hospital

What they're measuring

Desirability of Outcome Ranking (DOOR)

Timeframe: From enrollment to 30 days post enrollment

Trial details

NCT IDNCT07376889

SponsorIntermountain Health Care, Inc.

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2029-01

Contact for this trial

Brandon J Webb, MD

801-507-7781 Brandon.Webb@imail.org

View on ClinicalTrials.gov More Staphylococcus Aureus Bacteremia trials